Member Info for stephen11

Peel Hunt obviously think GDR is worth a keeping - for a while anyway!

Would it not be more prudent for Peel Hunt to let the SP rise steadily prior to Nice news?

Getting, for example a 100% rise on the 10th July off of 2.5/3p would be better than bouncing of 1.5p.

Makes no sense for them to want to manipulate or suppress the sp, especially when they want to offload shares at a profit.

In hindsight Peel Hunt is to be applauded 👏.

The placing might have collapsed without their intervention, and as a few have wisely pointed out, they are selling in an orderly fashion.

Better days ahead for GDR 😊

...and 6% up on HL.

Not a bad start for a Monday morning.

Fair play ProfessorSPD - I sincerely hope you and the rest of us get back in profit soon 😊.

Indeed, reminiscent of a flickering candle 🕯️ in a darkened room - the harimi cross is a sign of more positive trading days ahead.

Is not holding the CEO to account fast enough.

In perspective, James Cheek and his predecessor David Budd earn more money per year than either Rishi Sunak, on £164,000 per year, and Joe Biden, on £316,000. Yet do they earn their money, are they held accountable for missed targets, and is pay, performance related in any way?

94% of PI's saved this company from a very precarious position by participating in the placing, saving the company from possible insolvency. Lets not be flippant about this.

JC and the sales team need to be held to the fire with regards to sales, commercial traction, and the controlling of cash burn. I've previously managed a team of 50 staff, and would have got a call from the regional manager if the monthly wage bill was £5.00 adverse to target. Each yearly KPIs would be scrutinised at my annual review, and rightly so.

I'll give you an example. At JCs first meeting on the 30th Nov 2023 he stated that the company were actively seeking sales around Europe for the stroke test, on a research only basis. No sales materialised, and fast forward to 5th April 2024, and JC states again sales are being lined up around Europe on a research only basis - WE NEED SALES AND NOT EMPTY PROMISES.

He (James Cheek) also made comments in Nov 2023 that made some PIs believe specialist commissioning for the hearing loss assay was imminent, though had to back-Trak in April.

Rant over!

GLA.

Stephen11.

It can be quite difficult to get your head around the impact of dilution.

Basically, prior to the fund raise we had 153m shares on issue, compared to 543.14m now. This means we have a multiple of 3.55 more shares on issue at present.

What does this mean in terms of the "OLD" and "NEW" SP.

£2.00 in old money would now be an SP of 56p now

£1.00 = 28p

50p = 14.29p

25p = 7p

20p = 5.63p

10p = 2.82p

5p = 1.41p

So, for me, 15p is more than doable this year. We previously hit £2.00 on the rumour of sales for the Covid test, but those were crazy, when you consider Novacyt went from a few pence to over £10.00.

Why wouldn't we get the full NICE accreditation for the stroke assay - how much more evidence do they need?

The test distinguishes individuals who would have an adverse reaction from clopidogrel, and allows for the administration of a more appropriate drug, in a timely manner.

Whats not to like or be excited about GDR having a regular income stream from July?

GLA.

Stephen11.

50p will do for a takeover - i'm not greedy - that will keep me in cruise holidays and white wine well into my retirement!

Warming up to be a very pleasant end to the week!

It’s a good thing that Peel Hunt have reduced their holdings.

Makes it more likely that they have no interest in a takeover.

Just trying to make a shilling or two like the rest of us 😊.

543m shares on issue.

As a rough guide every 1p increase is an extra 5.25m on the Mcap.

I’m expecting a slow and steady build leading up to Nice on the 10th July.

Additionally, we could see an RNS presenting a US distribution partner, to help with FDA - not to be confused with the clinical partner that we have in place - one helps with validation and the other sales, distribution, and FDA advice 😊

You must do 🤔

Ooooh…do you do think 🤔 we have hope 😃

Why don’t you cut your losses and get out now then Joey?

Thanks PadRock - you seem to be doing your due deligence anyway. I suppose we will need to all just wait and see.

The good thing is there is a high percentage of pi’s on averages varying from 3p to £2.00 (I kid you not - one guy has an average of over £2.00) so they’ll not want this sold on the cheap.

I’ll be on the warpath if they try to get me out for 3.5p after 4 years - make no mistake about that.

No offence Padlock, although I have to ask - your doing quite a lot of scaremongering - are you looking to top up ⬆️ at a cheaper price?

It’s a start 😊

Not Ebitda positive yet, although full Nice accreditation in July and the prospect of £8m in time is the best thing that has happened to GDR in the last 4 years 👍.

I hope Gino remembers how to use a sales ledger, unfortunately he hasn’t had much call for one recently.

Hope are resource upgrade is as good as Zinnwalds this morning - they got a factor of X 3.2 - happy 😃 to be in both stocks 👍